Avalyn Pharma (AVLN) vs Harrow (HROW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Harrow is the larger company by market cap ($1.13 billion vs $1.10 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVLN | HROW |
|---|---|---|
| Share price | $24.85 | $30.14 |
| Market cap | $1.10B | $1.13B |
| 1-day change | -2.66% | -1.57% |
| YTD return | — | -37.51% |
| 1-year return | — | -26.92% |
| 5-year return | — | +209.61% |
| Forward P/E | — | 10.87 |
| EPS (TTM) | $-2.47 | $-0.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $40.17 | $54.85 |
| 52-week low | $24.15 | $28.54 |
| Distance from 52-week high | -38.14% | -45.05% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +148.69% | +115.66% |
| Average volume | 234.81K | 555.14K |
| Shares outstanding | 44.33M | 37.49M |
| Employees | 55 | 373 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Avalyn Pharma
AVLN stock →Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 55 employees
About Harrow
HROW stock →Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments.
Health Care · Biotechnology: Pharmaceutical Preparations · 373 employees
AVLN vs HROW FAQ
Which is bigger, Avalyn Pharma or Harrow?
Harrow (HROW) is larger, with a market capitalization of $1.13B compared with $1.10B for Avalyn Pharma (AVLN).
Are Avalyn Pharma and Harrow in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.